Breakthroughs in Health & Medicine | Trends in Finance 
VOL. 1. NO. 19  |  June 12th, 2017
  
The Business of Beauty and Aesthetics
For the first time ever, Americans spent more than $15 billion in 2016 on combined surgical and nonsurgical procedures. Find out the reason behind the boom in non-surgical skin-tightening treatments, and Life Care Medical Device's own non-invasive therapy with minimal side effects. 
 
Special: Guide to Healthcare Companies Presenting at the Marcum Conference
For healthcare investors, we have created an expanded summary and a handy schedule of the 65 companies presenting at the Marcum Microcap Conference.  
 
Interviews
Andre DiMino: CEO of ADM Tronics on rollout of hearing protection products
 
Ideas & Technologies
BioKier's medical foods can treat diabetes 
TransOne's minimally invasive spine technology to treat degenerative conditions of the spine 
ProLung's improved outcomes for lung cancer patients via early predictive technologies 
BioElectronics' non-invasive electroceutical treatment for pain
 
Industry News
Recap of the 5th Annual SEBP Conference in Shanghai
1st World Tinnitus Congress in Warsaw 
BIO International Convention in San Diego    
 
The Business of Beauty & Aesthetics

For the first time ever, Americans spent more than $15 billion on combined surgical and nonsurgical procedures, according to the latest statistics reported by the American Society for Aesthetic Plastic Surgery (ASAPS). Also, according to ASPS statistics there were 17.1 million surgical and minimally invasive cosmetic procedures performed in the United States in 2016.
  
Last year, there was an 11% increase in total procedures from 2015 to 2016, representing a $1.5 billion increase in overall expenditures.Surgical procedures accounted for 56% and nonsurgical for 44% of the total spend.
  
Understanding the complete usage and application of devices is also difficult. Development of more advanced, efficient, and reliable devices is likely to offer significant opportunities in the market. One of these companies is Life Care Medical Devices, or LCMD...(more)

Special: Guide to Healthcare Companies at Marcum Conference

The 6th Marcum Microcap conference this week (June 15 and 16). For our readers who are attending we are compossing a guide to the 65 healthcare firms participating. A few highlights from the Guide: 
 
ProMIS Neurosciences [PMN.TO] is a Toronto-based company that has seen their stock double in the last few months as investors are learning that they may be on to a breakthrough in the treatment of Alzheimers. They present at 2:00pm on Thursday June 15. Here is link to 90 second CEO interview.
 
ADM Tronics [ADMT] is a little known microcap that is now coming out with new products to tackle some large and under-served markets such as tinnitus and pain. They present at 2:30PM on Thursday, June 15th  
 
Histogen [private] is a regenerative medicine company developing innovative products from cells grown under simulated embryonic conditions. They present at 10:30AM on Friday, June 16th.
 
Life Care Medical [private] has developed a new approach to skin tightening that is regarded by the industry as the "holy grail" of aesthetics. They are presenting on Thursday, June 15th at 4:00PM.
 
Angionetics [private] is developing angiogenic, gene-based bio-therapeutics to treat up to 1.2 million patients with late-stage coronary artery disease. They are presenting at 9:30AM on Friday, June 16.
 
Stroma Medical [private] has a permanent eye lightening technology that is nearing clinical results. They are presenting on Friday, June 16th at 11AM.
  
For a copy of the Guide email us at: info@onemedmarket.com. Register for conference  here
INTERVIEWS
Andre DiMino: CEO of ADMT on Hearing Protection 
 
Andre DiMino is the CEO of ADM Tronics, a medical device company that not only works to bring a product through the conceptual stage, but is also involved in the engineering, development, regulatory and manufacturing aspects.
 
ADMT is launching three new products in the near future: the Aurex-3, the Tinnitus Shield and Sonotron. The Aurex-3, an electronic therapy device designed to treat the nearly 50 million people in the United States and some 250 million worldwide suffering from tinnitus. Similarly, the Tinnitus Shield will prevent the onset of tinnitus. Lastly, the company plans to  file Sonotron with the FDA, a non-invasive therapy that applies a special pulsed long-wave radio frequency to painful joints. 

Click here to read the full transcript. 
IDEAS & TECHNOLOGIES
BioKier's Medical Foods Treat Diabetes
BioKier Inc. is an early-stage pharmaceutical company developing new proprietary medical foods and drugs for diabetes and related disorders. BioKier has identified a therapeutic opportunity and is developing a novel oral product for type 2 diabetes. This oral capsule will potentially also have effects in metabolic syndrome and obesity... (more)

TranS1's Spinal Condition Treatments
TranS1 is a medical device company focused on providing elegant solutions to surgeons that minimize the damage caused by surgical approaches to the spine. TranS1's foundational solution, AxiaLIF+, requires only a 2 cm incision size, which reduces blood loss, inpatient stay, and interoperative time - all while achieving a 94% fusion rate... (more) 

BioElectronics' Electroceutical Med Devices
BioElectronics Corporation is the leading company in the field on non-invasive electroceutical medical devices.
BioElectronics' innovative medical devices safely and effectively treat chronic and acute pain through a unique mechanism of non-invasive sub-sensory neuromodulation.
BioElectronics medical devices have been used in a series of high quality clinical trials many of which have been peer reviewed and published in high quality medical journals including... (more) 

ProLung's Cancer Technologies
ProLung's mission is to improve outcomes for potential lung cancer patients through early predictive technologies, provide cost savings to patients, payers, and providers, and to provide a fair return on investment to shareholders and other stakeholders.  ProLung is committed to making a positive and significant impact on the healthcare community and to being socially responsible in all its endeavors... (more)

INDUSTRY NEWS
5th Annual SEBP Conference in Shanghai
On May 15th and 16th, China BioVentures sponsored the Sino-Euro BioPartnering event (SEBP) at the Fenglin Biomedical Center in Shanghai, China. The Fenglin Biomedical Center was created and supported by the Chinese government to introduce leading international biomedical...(more)

1st World Tinnitus Congress in Warsaw
The World Tinnitus Congress was held in Warsaw, Poland from the 22nd to the 24th of May. The primary goal of this congress was to bring together both the experienced and the up-and-coming scientists and clinicians to actively discuss the latest ideas, results and challenges within the world of tinnitus...(more)
 
BIO International Convention in San Diego
The BIO International Convention is being held from June 19th to 22nd in San Diego, California. The event is being held at the San Diego Convention Center. The BIO International Convention is hosted by the Biotechnology Innovation Organization (BIO)... (more) 
 
For information on presenting at 2017 MARCUM:    Public Companies  |   Private Companies 
STAY CONNECTED: